Skip to main content
Back
Watch Compare

PANACEA LIFE SCIENCES HOLDINGS, INC.

Data quality: 100%
PLSH
OTC Manufacturing Chemicals
$0.04
$0.00 (0.00%)
Mkt Cap: 827,727.0
Price
$0.04
Mkt Cap
827,727.0
Day Range
$0.04 — $0.05
52-Week Range
$0.03 — $0.20
Volume
29,999
Open $0.05
50D / 200D Avg
$0.04
10.96% below
50D / 200D Avg
$0.05
28.04% below

Quick Summary

Key Takeaways

Revenue grew 62.07% annually over 5 years — strong growth
Negative free cash flow of -1.62 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 15.48%
Capital efficient — spends only 1.99% of revenue on capex

Growth

Revenue Growth (5Y)
62.07%
Above sector avg (1.82%)
Revenue (1Y)46.59%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net Margin-277.51%
Op. Margin-192.25%

Safety

Debt / Equity
N/A
Current Ratio0.23
Interest Coverage-3.31

Valuation

PE (TTM)
-0.11
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.1 -1.5
P/B — 1.6
ROE % — -53.4
Net Margin % -277.5 -41.5
Rev Growth 5Y % 62.1 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 46.59% Revenue Growth (3Y) 7.61%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 62.07% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.76 M Net Income (TTM) -7.67 M
ROE N/A ROA -42.44%
Gross Margin 56.53% Operating Margin -192.25%
Net Margin -277.51% Free Cash Flow (TTM) -1.62 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.23
Interest Coverage -3.31 Asset Turnover 0.15
Working Capital -15.75 M Tangible Book Value -15.65 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.11 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.30
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -196.06%
Market Cap 827,727.0 Enterprise Value 720,084.0
Per Share
EPS (Diluted TTM) -0.57 Revenue / Share 0.13
FCF / Share -0.08 OCF / Share -0.07
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.99% FCF Conversion 21.16%
SBC-Adj. FCF N/A Growth Momentum -15.48

Income Statement

Annual, most recent first
Metric FY2023 FY2022 FY2021 FY2020 FY2019
Revenue 2.38 M 1.63 M 2.06 M 2.07 M 345,680.0
Net Income -8.02 M -9.14 M -4.78 M -10.94 M -10.22 M
EPS (Diluted) -0.48 — — — —
Gross Profit 1.12 M 396,470.0 540,578.0 -648,616.0 -1.70 M
Operating Income -5.55 M -5.65 M -5.94 M -10.55 M -10.88 M
EBITDA — — — — —
R&D Expenses — — — 0.0 22,100.0
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 1.56 M 2.05 M 1.11 M 1.00 M 479,111.0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2023 FY2022 FY2021 FY2020 FY2019
Total Assets 17.98 M 19.49 M 23.78 M 71,268.0 9.80 M
Total Liabilities 26.27 M 21.63 M 16.68 M 5.11 M 6.12 M
Shareholders' Equity -8.29 M -2.14 M 7.10 M -3.26 M 4.22 M
Total Debt — — — 335,510.0 185,906.0
Cash & Equivalents 100,922.0 6,951.0 19,774.0 25,139.0 18,405.0
Current Assets 4.66 M 6.38 M 9.10 M 51,109.0 2.43 M
Current Liabilities 19.45 M 15.07 M 10.07 M 4.90 M 4.19 M